Living Technologies
4445
Chiome Bioscience
4583
Btm
5247
EURASIA TRAVEL
9376
And Factory
7035
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -4.28%75.69B | -3.83%75.87B | 2.46%73.49B | 11.82%309.77B | 6.61%80.08B | 3.44%79.08B | 26.34%78.89B | 13.80%71.72B | 22.13%277.03B | 19.18%75.11B |
Cost of revenue | -3.89%68.08B | -3.43%68.9B | 3.53%67B | 11.02%278.92B | 5.29%72.02B | 2.73%70.84B | 25.87%71.34B | 13.14%64.72B | 21.54%251.24B | 18.70%68.4B |
Gross profit | -7.65%7.61B | -7.64%6.97B | -7.40%6.48B | 19.62%30.85B | 20.05%8.06B | 9.95%8.24B | 30.99%7.55B | 20.29%7B | 28.19%25.79B | 24.34%6.71B |
Operating expense | 2.63%4.87B | 10.50%5B | 11.49%4.81B | 10.28%18.6B | 15.18%5.01B | 8.18%4.75B | 8.65%4.52B | 8.93%4.32B | 11.19%16.86B | 7.57%4.35B |
Operating profit | -21.61%2.74B | -34.77%1.97B | -37.77%1.67B | 37.25%12.26B | 29.02%3.05B | 12.46%3.49B | 89.13%3.03B | 44.51%2.69B | 80.20%8.93B | 74.34%2.36B |
Net non-operating interest income (expenses) | 9.58%-236M | -6.58%-243M | 22.68%-208M | -18.65%-935M | 33.71%-177M | -8.30%-261M | -49.02%-228M | -111.81%-269M | -205.43%-788M | -423.53%-267M |
Non-operating interest income | 146.15%192M | 225.00%182M | 450.00%209M | 1,471.43%550M | 1,618.18%378M | 1,200.00%78M | 1,020.00%56M | 1,800.00%38M | 34.62%35M | 120.00%22M |
Non-operating interest expense | 26.25%428M | 49.65%425M | 35.83%417M | 80.44%1.49B | 92.04%555M | 37.25%339M | 79.75%284M | 137.98%307M | 189.79%823M | 373.77%289M |
Net investment income | -1,192.00%-546M | -108.67%-15M | 4,700.00%192M | 94.28%-25M | 37.16%-252M | 135.21%50M | 5,866.67%173M | -96.33%4M | -191.61%-437M | -245.82%-401M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | 52.38%-10M | 314.63%88M | -232.69%-69M | 471.43%26M | 158.06%36M | 51.16%-21M | -165.08%-41M | 48.57%52M | 78.79%-7M | -55.00%-62M |
Special income (charges) | -298.31%-117M | 26.09%58M | -9.30%39M | 222.41%213M | 62.50%65M | 37.21%59M | 115.08%46M | -10.42%43M | -201.16%-174M | 14.29%40M |
Less:Other special charges | 298.31%117M | -26.09%-58M | 9.30%-39M | -222.41%-213M | -62.50%-65M | -37.21%-59M | -115.08%-46M | 10.42%-43M | 201.16%174M | -14.29%-40M |
Other non-operating income (expenses) | -53.60%58M | -40.00%102M | 7.65%211M | -27.46%317M | -187.88%-174M | 32.98%125M | 25.00%170M | 2,077.78%196M | -29.63%437M | 55.91%198M |
Income before tax | -45.30%1.89B | -37.48%1.97B | -32.26%1.84B | 48.89%11.85B | 36.18%2.55B | 22.33%3.45B | 135.13%3.15B | 40.23%2.71B | 34.12%7.96B | 9.99%1.87B |
Income tax | -70.45%383M | -6.05%1.07B | 11.74%866M | 13.69%3.67B | -17.41%460M | 34.30%1.3B | 42.86%1.14B | -14.74%775M | 136.73%3.23B | 36.19%557M |
Net income | -30.22%1.5B | -55.33%896M | -49.85%971M | 72.96%8.18B | 58.90%2.09B | 16.14%2.15B | 271.48%2.01B | 89.06%1.94B | 3.50%4.73B | 1.70%1.31B |
Net income continuous operations | -30.14%1.5B | -55.33%896M | -49.87%971M | 72.92%8.18B | 58.90%2.09B | 16.09%2.15B | 271.48%2.01B | 88.98%1.94B | 3.50%4.73B | 1.70%1.31B |
Noncontrolling interests | -250.00%-3M | -400.00%-9M | -650.00%-15M | -33.33%-4M | -250.00%-7M | -85.71%2M | 115.79%3M | -150.00%-2M | -137.50%-3M | -150.00%-2M |
Net income attributable to the company | -29.93%1.51B | -54.80%905M | -49.15%986M | 72.93%8.19B | 59.39%2.1B | 16.80%2.15B | 258.14%2B | 90.10%1.94B | 3.77%4.73B | 2.18%1.32B |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -29.93%1.51B | -54.80%905M | -49.15%986M | 72.93%8.19B | 59.39%2.1B | 16.80%2.15B | 258.14%2B | 90.10%1.94B | 3.77%4.73B | 2.18%1.32B |
Gross dividend payment | ||||||||||
Basic earnings per share | -29.95%31.95 | -54.70%19.22 | -48.88%20.96 | 73.37%173.56 | 60.03%44.52 | 17.31%45.61 | 258.97%42.43 | 89.90%41 | 3.71%100.11 | 2.09%27.82 |
Diluted earnings per share | -29.95%31.92 | -54.71%19.2 | -48.86%20.94 | 73.41%173.38 | 60.08%44.47 | 17.36%45.57 | 258.93%42.39 | 89.94%40.95 | 3.72%99.98 | 2.09%27.78 |
Dividend per share | 0 | 50.00%24 | 0 | 41.94%44 | 75.00%28 | 0 | 6.67%16 | 0 | 3.33%31 | 6.67%16 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |